How Best to Manage Chronic Cholestasis

Total Page:16

File Type:pdf, Size:1020Kb

How Best to Manage Chronic Cholestasis ONLINE EXCLUSIVE Ignazio Grattagliano, MD; How best to manage Annarosa Floreani, MD; Enzo Ubaldi, MD; Piero Portincasa, MD chronic cholestasis Italian College of General Practitioners and Primary Care, Florence, Italy (Drs. Here’s how to maximize your use of lab work and Grattagliano and Ubaldi); Department of Surgery, imaging techniques to identify the source of your Oncology, and Gastroenterology, University patient’s cholestasis and provide prompt treatment. of Padua, Italy (Dr. Floreani); Section of Internal Medicine, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari, Italy (Dr. Portincasa) CASE u PRACTICE studiomedico@grattagliano. A 44-year-old nurse describes persistent fatigue and itching over RECOMMENDATIONS it the last 2 months. She is taking ramipril 5 mg/d for hypertension ❯ Suspect intrahepatic The authors reported no and has a family history of rheumatic disease. Lab tests reveal a cholestasis in a patient potential conflict of interest recurrent moderate elevation of gamma glutamyl-transpeptidase relevant to this article. with pruritus, normal transaminases, and mildly (gGT; 75 U/L) associated with, on some occasions, mild elevation elevated gamma glutamyl- of alanine aminotransferase (ALT) levels (100 U/L) of unknown transpeptidase and alkaline origin. She has no history of hepatitis virus infection, hepatotoxic phosphatase levels. A medications, or alcohol intake. She is overweight with a body 2 ❯ Use ultrasonography mass index of 28.5 kg/m and a waist circumference of 99 cm as a first-line diagnostic (39 inches). Liver ultrasonography detects an enlarged liver with tool for cholestasis. A diffuse echostructure dishomogeneity, but no signs of cirrhosis or portal hypertension. The patient’s biliary tree is not dilated. Strength of recommendation (SOR) How would you proceed with the care of this patient? A Good-quality patient-oriented evidence B Inconsistent or limited-quality holestasis is characterized by the alteration of bile flow patient-oriented evidence through any part of the biliary system, from the hepa- C Consensus, usual practice, tocyte basocellular membrane to the duodenum. The opinion, disease-oriented C evidence, case series condition is classified as intrahepatic when the cause is a de- fect of hepatocellular function or obstruction of the biliary tree within the liver. The extrahepatic form includes all conditions obstructing bile flow in the main biliary tract (choledochus, common bile duct). The key to successfully managing cholestasis lies in the early identification of subtle signs and symptoms before serious complications can arise. In the review that follows, we provide guidance for evaluating laboratory and imaging results that are vital to the accurate diagnosis of intrahepatic and extrahepatic cholestasis. We also detail treatment recommendations. Clues—subtle and otherwise— of cholestasis Clinical features of cholestasis include fatigue and itching all over the skin. The latter likely is caused by induction of MDEDGE.COM/JFPONLINE VOL 67, NO 7 | JULY 2018 | THE JOURNAL OF FAMILY PRACTICE E9 TABLE 1 What these serum parameters can tell you8 Alkaline phosphatase (ALP) ALP elevation follows accumulation of bile salts within biliary canalicula with a consequent solubili- zation of the enzyme bound to the canalicular membranes. ALP also is present in other tissues (eg, bone, kidney, gut, placenta), meaning that an isolated increase of ALP could be caused by extrahe- patic conditions. The simultaneous elevation of ALP and gGT (0.5-2.5 times the upper normal limit or 60-300 U/L and 19-95 U/L, respectively) strongly suggests a cholestatic condition. Gamma-glutamyltranspeptidase (gGT) A microsomal enzyme of hepatocytes, gGT is induced by several medications such as barbiturates and cyclosporine, chronic alcohol intake, and cholestasis. An isolated increase of gGT could suggest non- alcoholic fatty liver disease, excessive alcohol intake, or hepatotoxic drug use. Bilirubin Bilirubin is a later indicator of cholestasis. In conditions of biliary obstruction, plasma levels could reach values 30 to 50 times higher than normal levels (≤15 mg/dL). At very high levels (>20 mg/dL), bilirubin is toxic to the blood and brain. Suspect the enzyme autotaxin, which produces the ALP levels appear to be associated with more intrahepatic neuronal activator lysophosphatidic acid. aggressive disease and predict risk of liver cholestasis in Retention of pruritogenic substances that transplantation or death in patients with pri- a patient with normally are excreted into bile might contrib- mary biliary cholangitis (PBC).5,6 Lowering chronic itching, ute to pruritus as well.1 Jaundice, dark urine, ALP levels is associated with improved dis- normal and pale and fatty stools occur with advanced ease outcomes, including transplant-free transaminases, disease. However, a cholestatic condition can survival rates.5,7) and mildly be detected in asymptomatic patients with el- Elevated serum aminotransferase elevated gamma evated biochemical markers. levels (aspartate aminotransferase [AST] glutamyl- ❚ Mildly elevated gGT and/or alkaline >0.5 times the UNL or 17.5 U/L; ALT >0.5 times transpeptidase. phosphatase (ALP) (0.5-2.5 times the up- the UNL or >18 U/L) and bilirubin (>1.1 mg/ per normal limit [UNL] or 19-95 U/L and dL), with predominance of the conjugated 60-300 U/L, respectively2) in the presence of form (TABLE 18), suggest possible cholestasis. normal transaminase levels (<20 U/L) in an In light of such findings, a clinician’s next step asymptomatic patient can indicate chronic should be to distinguish intrahepatic from liver disease. Signs suggestive of significant extrahepatic conditions. (For a detailed list liver disease have been reported in many pa- of the causes of intra- and extrahepatic cho- tients with gGT or ALP elevation with good lestasis, see TABLES 24 and 3.9) sensitivity (65%) and specificity (83%) for a diagnosis of intrahepatic cholestasis.3 How- Patient’s history can provide ever, because abnormal gGT values are com- important clues mon and often resolve spontaneously, family A thorough patient history is especially im- physicians (FPs) may pay little attention to portant when cholestasis is suspected. Details this finding, thus missing an opportunity for about the patient’s occupation, environment, early identification and treatment. and lifestyle are key, as are the specifics of That’s why it’s important to schedule prescribed or over-the-counter medications follow-up testing within 6 months for asymp- and supplements that could be hepatotoxic tomatic patients with abnormal laboratory (TABLE 410). A number of exogenous sub- findings. Persistent elevation of gGT alone or stances can cause liver injury, and the use of accompanied by ALP and ALT elevation (ALT some herbal products (senna, black cohosh, >0.5 times the UNL or >18 U/L) is the most greater celandine, kava) have been linked to common feature of a chronic (>6 months) hepatitis and cholestasis.11 Ask patients about cholestatic condition.4 (In particular, elevated alcohol use and history of conditions associ- E10 THE JOURNAL OF FAMILY PRACTICE | JULY 2018 | VOL 67, NO 7 CHRONIC CHOLESTASIS TABLE 2 TABLE 3 Causes of intrahepatic Causes of extrahepatic cholestasis in adults4 cholestasis in adults9 Hepatocellular causes Intraductal causes Alcoholic and nonalcoholic steatohepatitis Benign obstruction: Post-surgical, post- traumatic, biliary stones Amyloidosis, sarcoidosis Choledocholithiasis Hepatic cirrhosis Infections: Tuberculosis Medications (See TABLE 4) Malignant obstruction: Cholangiocarcinoma, Paraneoplastic syndromes cancer of ampulla of Vater Parenteral nutrition Parasites: Ascaris Secondary cancers Primary sclerosing cholangitis Vascular conditions: Budd-Chiari syndrome, Extraductal causes congestive heart failure Chronic hypertrophic pancreatitis Viral hepatitis with cholestatic features Enlargement of lymph nodes in the hilum Cholangiocyte causes Mirizzi syndrome (biliary stone wedged in the Anatomical alterations: Caroli syndrome cystic duct) Abdominal Cystic fibrosis Pancreatic cancer ultrasonography Graft-versus-host disease Secondary neoplasms from gastrointestinal is a first-line IgG4-associated cholangitis cancers diagnostic tool for cholestasis. Intrahepatic cholestasis during pregnancy Medications ization of an enlarged choledochus (>7 mm) Primary biliary cholangitis or common hepatic duct (>5 mm) and an Primary sclerosing cholangitis intrahepatic bile duct diameter that is more than 40% larger than adjacent branches of Sclerosing cholangitis secondary to infections the portal vein.13 However, ultrasonography (AIDS) or ischemia (vasculitis) has a low diagnostic sensitivity for many con- AIDS, acquired immune deficiency syndrome. ditions (eg, 15% to 89% for detecting common bile duct stones),14 requiring other diagnostic ated with liver disease, such as diabetes, hy- procedures, such as endoscopic retrograde perlipidemia, and thyroid disorders. cholangiopancreatography (ERCP) or mag- netic resonance cholangiopancreatography Indicators pointing to cholestasis? (MRCP), before reaching a diagnosis. It’s time for ultrasonography ❚ For asymptomatic patients with cir- While biopsy is considered the gold standard rhosis or those at an early stage of liver for diagnosing and staging chronic cholestatic disease, ultrasound at 6-month intervals liver disease and can exclude an extrahepatic combined with serum liver function tests can obstruction, it should be employed only if be useful to track
Recommended publications
  • Progress Report Cholestasis and Lesions of the Biliary Tract in Chronic Pancreatitis
    Gut: first published as 10.1136/gut.19.9.851 on 1 September 1978. Downloaded from Gut, 1978, 19, 851-857 Progress report Cholestasis and lesions of the biliary tract in chronic pancreatitis The occurrence of jaundice in the course of chronic pancreatitis has been recognised since the 19th century" 2. But in the early papers it is uncertain whether the cases were due to acute, acute relapsing, or to chronic pan- creatitis, or even to pancreatic cancer associated with pancreatitis or benign ampullary stenosis. With the introduction of endoscopic retrograde cholangiopancreato- graphy (ERCP), there has been a renewed interest in the biliary complica- tions of chronic pancreatitis (CP). However, papers published recently by endoscopists have generally neglected the cholangiographic aspect of the lesions and are less precise and less well documented than papers published just after the second world war, following the introduction of manometric cholangiography3-5. Furthermore, the description of obstructive jaundice due to chronic pancreatitis, classical 20 years ago, seems to have been forgotten until the recent papers. Radiological aspects of bile ducts in chronic pancreatitis http://gut.bmj.com/ If one limits the subject to primary diseases of the pancreas, particularly chronic calcifying pancreatitis (CCP)6, excluding chronic pancreatitis secondary to benign ampullary stenosis7, cancer obstructing the main pancreatic duct8 9 and acute relapsing pancreatitis secondary to gallstones'0 radiological aspect of the main bile duct" is type I the most.common on September 25, 2021 by guest. Protected copyright. choledocus (Figure). This description has been repeatedly confirmed'2"13. It is a long stenosis of the intra- or retropancreatic part of the main bile duct.
    [Show full text]
  • Guideline for the Evaluation of Cholestatic Jaundice
    CLINICAL GUIDELINES Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition ÃRima Fawaz, yUlrich Baumann, zUdeme Ekong, §Bjo¨rn Fischler, jjNedim Hadzic, ôCara L. Mack, #Vale´rie A. McLin, ÃÃJean P. Molleston, yyEzequiel Neimark, zzVicky L. Ng, and §§Saul J. Karpen ABSTRACT Cholestatic jaundice in infancy affects approximately 1 in every 2500 term PREAMBLE infants and is infrequently recognized by primary providers in the setting of holestatic jaundice in infancy is an uncommon but poten- physiologic jaundice. Cholestatic jaundice is always pathologic and indicates tially serious problem that indicates hepatobiliary dysfunc- hepatobiliary dysfunction. Early detection by the primary care physician and tion.C Early detection of cholestatic jaundice by the primary care timely referrals to the pediatric gastroenterologist/hepatologist are important physician and timely, accurate diagnosis by the pediatric gastro- contributors to optimal treatment and prognosis. The most common causes of enterologist are important for successful treatment and an optimal cholestatic jaundice in the first months of life are biliary atresia (25%–40%) prognosis. The Cholestasis Guideline Committee consisted of 11 followed by an expanding list of monogenic disorders (25%), along with many members of 2 professional societies: the North American Society unknown or multifactorial (eg, parenteral nutrition-related) causes, each of for Gastroenterology, Hepatology and Nutrition, and the European which may have time-sensitive and distinct treatment plans. Thus, these Society for Gastroenterology, Hepatology and Nutrition. This guidelines can have an essential role for the evaluation of neonatal cholestasis committee has responded to a need in pediatrics and developed to optimize care.
    [Show full text]
  • Biliary Tract Cancer*
    Biliary Tract Cancer* What is Biliary Tract Cancer*? Let us answer some of your questions. * Cholangiocarcinoma (bile duct cancer) * Gallbladder cancer * Ampullary cancer ESMO Patient Guide Series based on the ESMO Clinical Practice Guidelines esmo.org Biliary tract cancer Biliary tract cancer* An ESMO guide for patients Patient information based on ESMO Clinical Practice Guidelines This guide has been prepared to help you, as well as your friends, family and caregivers, better understand biliary tract cancer and its treatment. It contains information on the causes of the disease and how it is diagnosed, up-to- date guidance on the types of treatments that may be available and any possible side effects of treatment. The medical information described in this document is based on the ESMO Clinical Practice Guideline for biliary tract cancer, which is designed to help clinicians with the diagnosis and management of biliary tract cancer. All ESMO Clinical Practice Guidelines are prepared and reviewed by leading experts using evidence gained from the latest clinical trials, research and expert opinion. The information included in this guide is not intended as a replacement for your doctor’s advice. Your doctor knows your full medical history and will help guide you regarding the best treatment for you. *Cholangiocarcinoma (bile duct cancer), gallbladder cancer and ampullary cancer. Words highlighted in colour are defined in the glossary at the end of the document. This guide has been developed and reviewed by: Representatives of the European
    [Show full text]
  • Pancreaticobiliary Ductal Union Gut: First Published As 10.1136/Gut.31.10.1144 on 1 October 1990
    1144 Gut, 1990, 31, 1144-1149 Pancreaticobiliary ductal union Gut: first published as 10.1136/gut.31.10.1144 on 1 October 1990. Downloaded from S P Misra, M Dwivedi Abstract TABLE ii Length ofthe common channel in normalsubjects in The main pancreatic duct and the common bile various series duct open into the second part of the duo- Authors Mean (mm) Range (mm) denum alone or after joining as a common Misra et al4 4-7 1-018-4 channel. A common channel of >15 mm (an Kimura et al5 4.6 2-10 anomalous pancreaticobiliary duct) is associ- Dowdy et al6 4-4 1-12 ated with congenital cystic dilatation of the common bile duct and carcinoma of the gall bladder. Even a long common channel channel of <3 mm, and 18% had a common (38 mm) is associated with a higher frequency channel of >3 mm. The rhean length was not of carcinoma of the gall bladder. Gail stones mentioned.2 In a necropsy study of 35 infants, smaller than the common channel and a long Miyano et al' noted that the average length of the common channel predispose to gail stone common channel was 1 3 mm. induced acute pancreatitis. Separate openings Kimura et al,' using cineradiography during for the two ductal systems predisposes to ERCP, have shown contractile motility of the development of gall stones and alcohol ductal wall extending well beyond the common induced chronic pancreatitis. The role of channel, towards the liver. The mean (SD) ductal union has also been investigated in length of the contractile segment was 20 5 primary sclerosing cholangitis and biliary (4 6) mm (range 14-31 mm).
    [Show full text]
  • What Is the Normal Size of the Common Bile Duct?
    DOI: https://doi.org/10.22516/25007440.136 Original articles What is the normal size of the common bile duct? Martín Alonso Gómez Zuleta, MD,1 Óscar Fernando Ruiz Morales, MD,2 William Otero Regino, MD.3 1 Internist and Gastroenterologist, Professor at the Abstract National University of Colombia. Gastroenterologist at National University of Colombia Hospital in Traditionally, the common bile duct (CBD) has been said to measure up to 6 mm in patients with gallbladders Bogotá, Colombia and up to 8 mm in cholecystectomized patients. However, these recommendations are based on very old 2 Internist and Gastroenterologist at Hospital Nacional studies performed with trans-abdominal ultrasound. Echoendoscopy has greater sensitivity and specificity for Universitario and Kennedy Hospital in Bogotá, Colombia evaluating the bile duct, but studies had not yet been done in our population to evaluate the normal size of 3 Internist and Gastroenterologist, Professor of the CBD by this method. Gastroenterology at the National University of Objective: The objective of this study was to evaluate the size of the CBD in patients with gallbladders and Colombia in Bogotá, Colombia patients without gallbladders. Materials and Methods: This is a prospective descriptive study of patients who underwent echoendoscopy ......................................... at the gastroenterology unit in the El Tunal hospital, Universidad Nacional de Colombia. Patients had been Received: 05-11-15 Accepted: 21-04-17 referred for diagnostic echoendoscopy to evaluate subepithelial lesions in the esophagus and/or stomach. Once the lesion had been evaluated and an echoendoscopic diagnosis had been established, the transducer was advanced to the second duodenal portion to perform bilio-pancreatic echoendoscopy.
    [Show full text]
  • Expression of Specific Hepatocyte and Cholangiocyte Transcription Factors
    Laboratory Investigation (2008) 88, 865–872 & 2008 USCAP, Inc All rights reserved 0023-6837/08 $30.00 Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development Pallavi B Limaye, Gabriela Alarco´n, Andrew L Walls, Michael A Nalesnik, George K Michalopoulos, Anthony J Demetris and Erin R Ochoa Transcription factors are major determinants of cell-specific gene expression in all cell types. Studies in rodent liver have shown that alterations in transcription factor expression determine lineage specification during fetal liver development and signify transdifferentiation of cells of the biliary compartment into ‘oval’ cells and eventually hepatocytes in adult liver. We examined the cellular localization of hepatocyte- or BEC-associated transcription factors in human fetal and adult liver and in diseases in which transdifferentiation between hepatocytes and biliary cells may play a role. In the normal adult human liver, hepatocyte nuclear factor (HNF)4a and HNF6 appeared exclusively in hepatocytes; HNF1b, HNF3a, and HNF3b were observed only in BEC. During fetal development both BEC and hepatocytes expressed HNF3a, HNF3b, and HNF6. HNF1a was expressed only in fetal hepatocytes. We further examined expression of transcription factors in massive hepatic necrosis and in specific types of chronic liver disease. Hepatocyte-associated transcription factors HNF4a and HNF6 also appeared in BEC in massive hepatic necrosis and chronic hepatitis C virus infection. Similarly, HNF3b that is expressed only in BEC in normal adult liver was also observed in hepatocytes in primary biliary cirrhosis and chronic biliary obstruction. These data mimic previous findings in rodents in which hepatocyte-associated transcription factors appear in biliary cells prior to emergence of oval cells, which function as progenitor cells for hepatocytes when the regenerative capacity of the latter is compromised.
    [Show full text]
  • Chronic Pancreatitis: Introduction
    Chronic Pancreatitis: Introduction Authors: Anthony N. Kalloo, MD; Lynn Norwitz, BS; Charles J. Yeo, MD Chronic pancreatitis is a relatively rare disorder occurring in about 20 per 100,000 population. The disease is progressive with persistent inflammation leading to damage and/or destruction of the pancreas . Endocrine and exocrine functional impairment results from the irreversible pancreatic injury. The pancreas is located deep in the retroperitoneal space of the upper part of the abdomen (Figure 1). It is almost completely covered by the stomach and duodenum . This elongated gland (12–20 cm in the adult) has a lobe-like structure. Variation in shape and exact body location is common. In most people, the larger part of the gland's head is located to the right of the spine or directly over the spinal column and extends to the spleen . The pancreas has both exocrine and endocrine functions. In its exocrine capacity, the acinar cells produce digestive juices, which are secreted into the intestine and are essential in the breakdown and metabolism of proteins, fats and carbohydrates. In its endocrine function capacity, the pancreas also produces insulin and glucagon , which are secreted into the blood to regulate glucose levels. Figure 1. Location of the pancreas in the body. What is Chronic Pancreatitis? Chronic pancreatitis is characterized by inflammatory changes of the pancreas involving some or all of the following: fibrosis, calcification, pancreatic ductal inflammation, and pancreatic stone formation (Figure 2). Although autopsies indicate that there is a 0.5–5% incidence of pancreatitis, the true prevalence is unknown. In recent years, there have been several attempts to classify chronic pancreatitis, but these have met with difficulty for several reasons.
    [Show full text]
  • Long-Term Prognosis for Infants with Intrahepatic Cholestasis and Patent Extrahepatic Biliary Tract
    Arch Dis Child: first published as 10.1136/adc.56.5.373 on 1 May 1981. Downloaded from Archives of Disease in Childhood, 1981, 56, 373-376 Long-term prognosis for infants with intrahepatic cholestasis and patent extrahepatic biliary tract M ODIEVRE, M HADCHOUEL, P LANDRIEU, D ALAGILLE, AND N ELIOT Unite de Recherche d'Hepatologie Infantile, INSERM U 56, and Clinique de Pediatrie, UniversiteParis-Sud, H6pital d'Enfants, France SUMMARY One hundred and three infants with prolonged cholestasis beginning before age 3 months were classified as having a-1-antitrypsin deficiency (17 patients), scanty interlobular bile ducts (16 patients), or 'neonatal hepatitis' (70 patients). Twenty-two gradually developed chronic liver disease and the remaining 81 recovered within a few months. Prognosis was found to be poor for infants with a- 1-antitrypsin deficiency, scanty interlobular bile ducts, and familial 'idiopathic' hepatitis. Patients who developed cirrhosis often presented with severe and persistent neonatal cholestasis, mimicking extrahepatic biliary atresia and leading to laparotomy. Thus, a high-risk group of infants-defined by aetiology, family history, and degree of cholestasis-can be recognised in the first months oflife. Most infants with prolonged cholestasis have either The 103 cases were classified as follows: extrahepatic biliary atresia or intrahepatic disease. Alpha-l-antitrypsin deficiency (n=17) demonstrated The prognosis for those with the latter is not clear; by low serum concentration and PiZ phenotype; in some factors-such as aetiology,1 2 familial one patient, only a retrospective diagnosis was occurrence,3 4 presence of a second disease4 -have possible, made after reviewing the liver histology.
    [Show full text]
  • The Diagnosis of the Gallbladder and the Biliary
    C Anatomic and physiologic considerations • The entoero-hepatic circulation of bilirubin • The hepatobilary tree • Characteristics of pain of biliary origin Diagnostic evaluation of the gallbladder Plain abdominal X-ray Low cost, readily available. Relatively low yield. Contraindicated in pregnancy. Pathognomic findings: calcified gallstones, limey bile, porcelain gallbladder, emphysematous cholecystitis, gallstone ileus Gallbladder ultrasound (US) Rapid; Accurate identification of gallstones (>95%); Simultaneous scanning of gallbladder, liver, bile ducts, pancreas; „Real-time” scanning allows assessment of gallbladder volume, contractility; May detect very small stones. Diagnostic limitations: Bowel gas, massive obesity, ascites, recent barium study. Not limited by jaundice, pregnancy. Procedure of choice to detect stones. Radioisotope scans (HIDA, DIDA, etc.) Accurate identification of cystic duct obstruction. Simultaneous assessment of bile ducts. Contraindicated in pregnancy and when se Bi >103-205 uM/L. Cholecystogram low resolution. Indicated for confirmation of suspected acute cholecystitis. Less sensitive and less specific in chronic cholecystitis. Useful in diagnosis of acalculous cholecystopathy, esp. if given with CCK to assess gallbladder emptying. Diagnostic evaluation of the bile ducts Hepatobiliary ultrasound Ultrasonography of duct stones is not as reliable as of those in the bile duct. Rapid; simultaneous scanning of gallbladder, liver, bile ducts, pancreas. Diagnostic limitations: bowel gas, massive obesity, ascites,
    [Show full text]
  • Ultrastructural Changes in Human Gall Bladder Epithelium in Cholelithiasis
    Dec QMJ VOL.8 No.12 Ultrastructural Changes In Human Gall Bladder Epithelium In Cholelithiasis Khalida I. Shaya*, Muna Zuhair**and Modhar S. Al-Omary*** اﻟﺨﻼﺻﺔ ﺗﻜﻮﯾﻦ اﻟﺤﺼﻮات اﻟﺼﻔﺮاوﯾﺔ ﯾﻌﺮف ﻋﻠﻰ اﻧﮫ وﺟﻮد ﺣﺼﻰ ﺿﻤﻦ ﺗﺠﻮﯾﻒ اﻛﯿﺎس اﻟﻤﺮارة او ﻓﻲ اﻟﺸﺠﯿﺮات اﻟﺼﻔﺮاوﯾﺔ اﻟﺨﺎرج ﻛﺒﺪﯾﺔ. اﻟﮭﺪف ﻣﻦ ھﺬه اﻟﺪراﺳﺔ ھﻮ اﻟﺘﻌﺮف ﻋﻠﻰ اﻟﺘﻐﯿﯿﺮات اﻟﻨﺴﯿﺠﯿﺔ اﻟﺪﻗﯿﻘﺔ ﻓﻲ اﻟﻨﺴﯿﺞ اﻟﻄﻼﺋﻲ ﻻﻛﯿﺎس اﻟﻤﺮارة ﻓﻲ ﺣﺎﻟﺔ ﺗﻜﻮﯾﻦ اﻟﺤﺼﻮات اﻟﺼﻔﺮاوﯾﺔ . ﻧﻤﺎذج اﻛﯿﺎس اﻟﻤﺮارة ﺟﻤﻌﺖ ﻣﻦ ﻣﺮﺿﻰ اﺟﺮﯾﺖ ﻟﮭﻢ ﻋﻤﻠﯿﺔ اﺳﺘﺌﺼﺎل اﻛﯿﺎس اﻟﻤﺮارة. اﻟﻨﻤﺎذج اﻟﺪﻗﯿﻘﺔ ﺣﻀﺮت و ﻋﻮﻣﻠﺖ ﻟﺪراﺳﺔ اﻟﺘﺮﻛﯿﺐ اﻟﻨﺴﯿﺠﻲ اﻟﺪﻗﯿﻖ ﻟﻠﻨﺴﯿﺞ اﻟﻄﻼﺋﻲ ﻻﻛﯿﺎس اﻟﻤﺮارة . اﻟﺘﻐﯿﯿﺮات اﻟﻨﺴﯿﺠﯿﺔ اﻟﻈﺎھﺮة ﻓﻲ اﻟﻤﻘﺎﻃﻊ اﻟﺸﺒﮫ رﻗﯿﻘﺔ ﻟﺼﺒﻐﺔ اﻟﻤﺜﯿﻞ اﻻزرق اﻇﮭﺮت وﺟﻮد ﺗﻤﺰﻗﺎت ﻣﻊ ﻋﺪم ﺗﻤﺎﺳﻚ ﻓﻲ اﻟﻨﺴﯿﺞ اﻟﻄﻼﺋﻲ ﻟﻠﻤﺮارة ﻣﺘﺮاﻓﻘﺎ ﻣﻊ ﻇﮭﻮر ﺗﺠﺎوﯾﻒ روﻛﺘﺎﻧﺴﻜﻲ اﺷﻮف ﻣﻊ وﺟﻮد ﺗﻀﺨﻢ وﻋﺪم اﻧﺘﻈﺎم اﻟﺘﻨﺎﺳﻖ ﻓﻲ اﻟﺨﻼﯾﺎ اﻟﻄﻼﺋﯿﺔ ﻣﻊ ﺣﺆول ﻓﻲ اﻟﻐﺪد اﻟﻤﺨﺎﻃﯿﺔ ﻓﻲ اﻟﺼﻔﯿﺤﺔ اﻟﺮﻗﯿﻘﺔ ﻻﻛﯿﺎس اﻟﻤﺮارة. ﻓﺤﺺ اﻟﺘﺮﻛﯿﺐ اﻟﻨﺴﯿﺠﻲ اﻟﺪﻗﯿﻖ اﻇﮭﺮ وﺟﻮد ﺳﺤﺞ ﻓﻲ اﻟﺰﻏﯿﺒﺎت اﻟﺪﻗﯿﻘﺔ ﻣﻊ ﺗﺤﻄﻢ ﻟﺒﯿﻮت اﻟﻄﺎﻗﺔ و ﺗﻮﺳﻊ ﻓﻲ اﻟﻔﺮاﻏﺎت ﺑﯿﻦ اﻟﺨﻠﻮﯾﺔ ﻣﺘﺰاﻣﻨﺎ ﻣﻊ ﻇﮭﻮر اﻟﻔﺠﻮات ﻓﻲ داﺧﻞ اﻟﺨﻼﯾﺎ اﻟﻄﻼﺋﯿﺔ ﻣﻊ وﺟﻮد ﻋﺪم اﻧﺘﻈﺎم و اﻧﻔﺘﺎق ﻓﻲ ﻣﺤﯿﻂ اﻟﺨﻼﯾﺎ. اﻟﺨﻼﯾﺎ اﻟﻄﻼﺋﯿﺔ اﺣﺘﻮت ﻋﻠﻰ ﻗﻄﯿﺮات ﻣﺨﺎﻃﯿﺔ، ﺷﻮھﺪ ﺑﻌﻀﮭﺎ ﻣﻔﺮزا اﻟﻰ ﺧﺎرج اﻟﺨﻠﯿﺔ . ﺣﺼﻰ اﻟﻤﺮارة ﯾﺮاﻓﻘﮭﺎ ﺗﻐﯿﯿﺮات ﻧﺴﯿﺠﯿﺔ اﺳﺎﺳﯿﺔ ﻓﻲ اﻻﻧﺴﺠﺔ اﻟﻄﻼﺋﯿﺔ ﻛﻤﺎ ﻇﮭﺮت ﻓﻲ اﻟﻤﺠﮭﺮﯾﻦ اﻟﻀﻮﺋﻲ و اﻻﻟﻜﺘﺮوﻧﻲ . ﻣﻔﺘﺎح اﻟﻜﻠﻤﺎت: اﻛﯿﺎس اﻟﻤﺮارة، ﺗﻜﻮﯾﻦ اﻟﺤﺼﻮات اﻟﺼﻔﺮاوﯾﺔ، اﻟﺘﻐﯿﺮات اﻟﻨﺴﯿﺠﯿﺔ اﻟﺪﻗﯿﻘﺔ. Abstract Cholelithiasis is defined as the presence of stones within the lumen of the gall bladder or in the extrahepatic biliary tree. The goal of this study was to identify the ultrastructural ultrations of gall bladder epithelium in cholelithiesis. Gallbladder specimens were collected from patients who underwent cholectstectomy. Minute specimens were also fixed and processed to evaluate the fine structures of the gall bladder epithelium.
    [Show full text]
  • Anatomic Variations of Extrahepatic Bile Ducts and Evaluation of the Length of Ducts Composing the Cystohepatic Triangle
    Int. J. Morphol., 30(1):279-283, 2012. Anatomic Variations of Extrahepatic Bile Ducts and Evaluation of the Length of Ducts Composing the Cystohepatic Triangle Variaciones Anatómicas de los Ductos Biliares Extrahepáticos y Longitud de los Ductos del Trígono Hepato-cístico *Eduardo Cachoeira;*Antonio Rivas & **Carla Gabrielli CACHOEIRA, E.; RIVAS, A. & GABRIELLI, C. Anatomic variations of extrahepatic bile ducts and evaluation of the length of ducts composing the cystohepatic triangle. Int. J. Morphol., 30(1):279-283, 2012. SUMMARY: It is of paramount importance for surgeons to have a thorough knowledge of the normal anatomy of the extrahepatic bile ducts and its variations due to the high frequency with which they perform in this anatomic site. The cystohepatic triangle, or Calot’s Triangle, is bound by the cystic duct, common hepatic duct, and the hepatic border; therefore, its surface area depends on the conformation of these ducts and is closely linked to surgical procedures performed in this region. It has been reported that the length and the position of these ducts may be related to the formation of bile duct stones, Mirizzi’s syndrome, and bile duct cancer. Thus, the present work aims to analyze the configuration of the extrahepatic biliary tree and its possible variations, as well as measure the components that make up the cystohepatic triangle. For this task 41 samples from fixated human cadavers were analyzed, with 25 consisting of anatomic parts (liver and biliary tree) and 16 in situ samples. The extrahepatic biliary trees were dissected in order to measure the length of the common hepatic and cystic ducts with a digital caliper, and all anatomic variations were registered.
    [Show full text]
  • The Biliary System, Second Edition the Biliary System
    WAN G • ET AL G • ET WAN Colloquium Lectures on Series ISSN: 2154-560X Integrated Systems Physiology From Molecule to Function to Disease LIFE SCIENCES Series Editors: D. Neil Granger, LSU Health Sciences, Shreveport Joey Granger, University of Mississippi Medical Center The Biliary System, Second Edition The Biliary System David Q.-H. Wang, Saint Louis University, USA THE BILIAR Brent A. Neuschwander-Tetri, Saint Louis University, USA Piero Portincasa, Saint Louis University and University of Bari Medical School, Italy Second Edition The biliary system is a complex network of microscopic and macroscopic structures involved in the formation of bile, an aqueous fluid in which a considerable amount of otherwise immiscible cholesterol is transported by other Y SYSTEM Y lipids such as bile acids and phospholipids. This book summarizes current understanding of the molecular and cellular mechanisms of cholesterol and bile acid metabolism, as well as the physical-chemistry of biliary lipids, with an emphasis on biliary lipid metabolism that is regulated by nuclear receptors in the hepatobiliary system. By guiding readers through the various aspects of anatomy, physiology, and biochemistry of all “players” involved in bile formation, this book is intended to be a manageable, easy-to-study compendium of recent EDITION SECOND , progresses in understanding the molecular mechanisms of cholesterol and bile acid metabolism. The authors clearly explain the molecular and cellular pathways that regulate hepatic lipid metabolism, and present color figures, tables, and flowcharts that explain the fundamental mechanisms of lipid synthesis and secretion, bile formation, the enterohepatic circulation, and intestinal absorption of biliary components. Moreover, the consequences of the complex events involving lipid metabolism in the hepatobiliary system are reviewed, with a focus on the translational value of current basic research in health and disease.
    [Show full text]